KVHI:NASDAQKVH Industries, Inc. Analysis
Data as of 2026-05-31 - not real-time
$9.28
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: KVHI is trading at $9.28, comfortably above the computed support of $9.12 but below the 20‑day SMA of $10.49, indicating a short‑term price cushion. The 20‑day SMA sits above the 50‑day SMA ($9.74) and the 200‑day SMA ($7.09), confirming a bullish long‑term trend. However, the MACD histogram is negative and the signal line is bearish, while RSI sits at 41, suggesting limited upside momentum in the near term.
Fundamental outlook: Revenue surged 27% YoY to $118 M, but margins remain thin (gross margin 25.6%, operating margin –0.4%, profit margin –4.3%). Cash of $59 M dwarfs debt of $4.3 M, giving a low leverage profile. Forward EPS of $0.75 translates to a forward P/E of 12.4, well below the industry average of 17.0, and the DCF‑derived fair value of $29.93 implies the stock is substantially undervalued. The market sentiment is extremely bullish (Fear & Greed Index 94).
Fundamental outlook: Revenue surged 27% YoY to $118 M, but margins remain thin (gross margin 25.6%, operating margin –0.4%, profit margin –4.3%). Cash of $59 M dwarfs debt of $4.3 M, giving a low leverage profile. Forward EPS of $0.75 translates to a forward P/E of 12.4, well below the industry average of 17.0, and the DCF‑derived fair value of $29.93 implies the stock is substantially undervalued. The market sentiment is extremely bullish (Fear & Greed Index 94).
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near immediate support with limited upside momentum
- Bearish MACD signal despite bullish SMA alignment
- High 30‑day volatility (≈78%)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth (27% YoY) and improving cash position
- Forward P/E of 12.4 vs industry 17.0 suggests value
- DCF fair value of $29.9 indicates significant upside potential
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to intrinsic valuation and peers
- Low leverage and solid cash reserves support strategic investments
- Global footprint diversifies revenue streams despite modest profitability
Key Metrics & Analysis
Financial Health
Revenue Growth27.20%
Profit Margin-4.31%
P/E Ratio12.4
ROE-3.78%
ROA-3.69%
Debt/Equity3.26
P/B Ratio1.4
Op. Cash Flow$10.1M
Free Cash Flow$14.6M
Industry P/E17.0
Technical Analysis
TrendBullish
RSI41.0
Support$9.12
Resistance$13.00
MA 20$10.49
MA 50$9.74
MA 200$7.09
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
Fair Value$29.93
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.68
Volatility78.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.